跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-007
首页
药物
A-007
A-007
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
US 2011105603 A1
申请人: AMERICAN LIFE SCIENCE PHARMACEUTICALS INC
优先权: 2010
US
2 件公开
EP 3296295 A1
申请人: AMERICAN LIFE SCIENCE PHARMACEUTICALS INC
优先权: 2009
EP
AXMI-007, a delta-endotoxin gene and methods for its use
US 2004210965 A1
申请人: ATHENIX CORP
优先权: 2004
US
Veterinary medicine composition for treating skin disease of fragrant pig
CN 102342960 A
申请人: UNIV TIANJIN AGRICULTURAL
优先权: 2011
CN
Method for acquiring Nogo-B knockout mode mouse based on CRISPR/Cas9 technology and application thereof
CN 108642090 A
申请人: CHINESE PLA GENERAL HOSPITAL
优先权: 2018
CN
Alpha-galactosidase as well as preparation method and application thereof
CN 112048495 A
申请人: UNIV FUDAN
优先权: 2019
CN
Construction method of mouse with Foxp3 gene knocked out under conditions
CN 111748582 A
申请人: AFFILIATED HOSPITAL QINGDAO UNIV
优先权: 2020
CN
Dendrobium officinale composition as well as preparation method and application thereof
CN 114404525 A
申请人: ZHEJIANG INDUSTRIAL UNIV
优先权: 2022
CN
Composition for reducing uric acid in serum and application thereof
CN 114984060 A
申请人: LIAONING BEIKERUI BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Application of AT-007 in prevention and treatment of androgenetic alopecia
CN 118286223 A
申请人: HANGZHOU THIRD PEOPLES HOSPITAL HANGZHOU HUIMIN HOSPITAL ZHEJIANG UNIV OF TRADITIONAL CHINESE MEDICI
优先权: 2024
CN
SMIC capture antibody, kit and application of sMIC capture antibody
CN 118294656 A
申请人: GUANGZHOU KONCEN BIOTECHNOLOGY CO LTD
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈